Inositol-1,4,5-trisphosphate-mediated spontaneous activity in mouse embryonic stem cell-derived cardiomyocytes

J Physiol. 2007 Jun 15;581(Pt 3):1113-27. doi: 10.1113/jphysiol.2006.125955. Epub 2007 Mar 22.

Abstract

Embryonic stem cell-derived cardiomyocytes (ESdCs) have been proposed as a source for cardiac cell-replacement therapy. The aim of this study was to determine the Ca2+-handling mechanisms that determine the frequency and duration of spontaneous Ca2+ transients in single ESdCs. With laser scanning confocal microscopy using the Ca2+-sensitive dye Fluo-4/AM, we determined that spontaneous Ca2+ transients in ESdCs at the onset of beating (day 9) depend on Ca2+ entry across the plasma membrane (50%) whereas Ca2+-induced Ca2+ release is the major contributor to Ca2+ transients in ESdCs after 16 days (72%). Likewise, Ca2+ extrusion in 9-day-old ESdCs depends on Na+-Ca2+ exchange (50.0+/-8%) whereas Ca2+ reuptake by the sarco(endo)plasmic Ca2+ ATPase (72+/-5%) dominates in further differentiated cells. Spontaneous Ca2+ transients were suppressed by the inositol-1,4,5-trisphosphate (IP3) receptor (IP3R) blocker 2-aminoethoxydiphenyl borate (2-APB) and the phospholipase C blocker U73122 but continued in the presence of caffeine. Stimulation of IP3 production by phenylephrine or endothelin-1 had a positive chronotropic effect that could be reversed by U73122 and 2-APB. The presence of Ca2+-free solution and block of L-type Ca2+ channels by nifedipine also resulted in a cessation of spontaneous activity. Overall, IP3R-mediated Ca2+ release in ESdCs is translated into a depolarization of the plasma membrane and a whole-cell Ca2+ transient is subsequently induced by voltage-dependent Ca2+ influx. Although ryanodine receptor-mediated Ca2+ release amplifies the IP3R-induced trigger for the Ca2+ transients and modulates its frequencies, it is not a prerequisite for spontaneous activity. The results of this study offer important insight into the role of IP3R-mediated Ca2+ release for pacemaker activity in differentiating cardiomyocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Action Potentials
  • Aniline Compounds
  • Animals
  • Boron Compounds / pharmacology
  • Calcium / metabolism
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels, L-Type / metabolism
  • Calcium Signaling* / drug effects
  • Cell Differentiation*
  • Cell Line
  • Embryonic Stem Cells / drug effects
  • Embryonic Stem Cells / metabolism*
  • Endothelin-1 / metabolism
  • Enzyme Inhibitors / pharmacology
  • Estrenes / pharmacology
  • Fluorescent Dyes
  • Heart Rate / drug effects
  • Heart Rate / physiology*
  • Inositol 1,4,5-Trisphosphate / metabolism*
  • Inositol 1,4,5-Trisphosphate Receptors / antagonists & inhibitors
  • Inositol 1,4,5-Trisphosphate Receptors / metabolism*
  • Mice
  • Microscopy, Confocal
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / metabolism*
  • Nifedipine / pharmacology
  • Phenylephrine / metabolism
  • Pyrrolidinones / pharmacology
  • Ryanodine Receptor Calcium Release Channel / metabolism
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases / metabolism
  • Sodium-Calcium Exchanger / metabolism
  • Time Factors
  • Type C Phospholipases / antagonists & inhibitors
  • Type C Phospholipases / metabolism
  • Xanthenes

Substances

  • Aniline Compounds
  • Boron Compounds
  • Calcium Channel Blockers
  • Calcium Channels, L-Type
  • Endothelin-1
  • Enzyme Inhibitors
  • Estrenes
  • Fluo 4
  • Fluorescent Dyes
  • Inositol 1,4,5-Trisphosphate Receptors
  • Pyrrolidinones
  • Ryanodine Receptor Calcium Release Channel
  • Sodium-Calcium Exchanger
  • Xanthenes
  • 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione
  • Phenylephrine
  • Inositol 1,4,5-Trisphosphate
  • 2-aminoethoxydiphenyl borate
  • Type C Phospholipases
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases
  • Nifedipine
  • Calcium